The Dose and Duration-dependent Association between Melatonin Treatment and Overall Cognition in Alzheimer's Dementia: A Network Meta- Analysis of Randomized Placebo-Controlled Trials.

Author: CarvalhoAndre F, ChenTien-Yu, ChenYen-Wen, ChengYu-Shian, HsuChih-Wei, LiDian-Jeng, LiangChih-Sung, LinPao-Yen, MatsuokaYutaka J, ShiueYow-Ling, StubbsBrendon, SuKuan-Pin, SunCheuk-Kwan, TsengPing-Tao, TuYu-Kang, WuYi-Cheng, YangChun-Pai, YehPin-Yang, ZengBing-Yan

Paper Details 
Original Abstract of the Article :
While Alzheimer's dementia (AD) has a prevalence as high as 3-32% and is associated with cognitive dysfunction and the risk of institutionalization, no efficacious and acceptable treatments can modify the course of cognitive decline in AD. Potential benefits of exogenous melatonin for cognition have...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886806/

データ提供:米国国立医学図書館(NLM)

Melatonin: A Potential Ally in the Fight Against Alzheimer's Dementia

Alzheimer's dementia (AD) is a devastating neurodegenerative disease, much like a relentless desert storm that erodes cognitive function. This network meta-analysis investigates the potential benefits of melatonin treatment for cognition in individuals with AD. The authors review a comprehensive dataset of randomized placebo-controlled trials, exploring the dose- and duration-dependent effects of melatonin on overall cognitive function.

Melatonin: A Promising Avenue for Cognitive Enhancement

This research, much like a desert traveler seeking a hidden oasis of knowledge, explores the potential of melatonin to mitigate the cognitive decline associated with AD. While the findings suggest a possible dose- and duration-dependent association between melatonin treatment and overall cognition, further research is needed to confirm these preliminary observations. This research paves the way for future investigations into the role of melatonin in managing AD and enhancing cognitive function.

Navigating the Desert of Alzheimer's Disease

This research, like a beacon of hope in the vast desert of Alzheimer's disease, offers potential avenues for improving cognitive function in individuals with AD. While more research is needed to fully understand the role of melatonin in treating this complex disease, these findings highlight the importance of exploring innovative therapeutic approaches to address this growing global health concern. As we continue to unravel the mysteries of AD, research like this provides valuable insights into potential treatment strategies.

Dr.Camel's Conclusion

This research, much like a camel caravan carrying a precious cargo of hope, delves into the potential of melatonin to improve cognitive function in individuals with Alzheimer's disease, offering a promising avenue for future research and potential treatment strategies.
Date :
  1. Date Completed 2022-09-16
  2. Date Revised 2023-03-01
Further Info :

Pubmed ID

35450525

DOI: Digital Object Identifier

PMC9886806

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.